AMR Patient Group AS FROM JUNE 2022, YOU CAN FIND ALL THE INFORMATION AND NEWS ABOUT THE AMR PATIENT GROUP HERE: https://amrpatientgroup.eu/ The first European AMR Patient Group was officially launched on the 18th November […]

My City-Lab Project My City-Labs Project is a joint initiative financed by the European Regional Development Fund (ERDF) to facilitate patients’ access to laboratory tests through the creation of two ambulatory care centres in Brussels. […]

The primary aim of the Interest Group on Innovation in Health and Social Care is to improve patient access to innovation in health and social care by influencing EU policy.

Antimicrobials, such as antibiotics, are substances used to kill microorganisms or to stop them from growing and multiplying. They are commonly used in both human and veterinary medicine to treat a wide variety of infectious diseases. The antimicrobial resistance (AMR) is the ability of a microorganism to resist the action of one or more antimicrobial agents. The alarming use of antimicrobials have transformed the microbial resistance in worldwide threat for the humanity that require immediate action across all government sectors and society. Read more insights on our White Paper

Patient Safety Patient safety is the absence of preventable harm to a patient during the process of health care and reduction of risk of unnecessary harm associated with health care to an acceptable minimum. The […]

Prevention and early diagnosis Knowledge is power: knowing a condition allows us to act promptly and prevent harm. Screening and early diagnosis play a key role in helping patients to live healthier and longer lives. Regular exams […]

Education and training We believe that the cornerstones to improve health systems performance and efficiency is to address the current challenges of a transforming care, starting from: Supporting workforce to meet the new demand of […]